Total planned funding: $1,705,261,243
Clear active filters
Nigeria
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $1,705,261,243 |
Organizational Types
NGO | $560,196,399 |
Private Contractor | $432,869,568 |
University | $335,060,453 |
Own Agency | $114,682,840 |
Unknown | $106,819,454 |
FBO | $91,755,837 |
Implementing Agency | $28,858,136 |
Other USG Agency | $23,890,574 |
Host Country Government Agency | $9,039,982 |
Multi-lateral Agency | $2,088,000 |
Program Areas
Treatment | $760,184,324 |
Care | $324,545,289 |
Prevention | $236,260,361 |
Governance and Systems | $226,102,706 |
Management and Operations | $88,572,234 |
Testing | $69,596,329 |
Budget Codes
HTXD: Treatment: ARV Drugs | $400,094,653 |
HTXS: Treatment: Adult Treatment | $339,430,683 |
HKID: Care: Orphans and Vulnerable Children | $149,837,475 |
HLAB: Laboratory Infrastructure | $124,266,829 |
HBHC: Care: Adult Care and Support | $115,214,302 |
HVMS: Management and Operations | $88,572,234 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $86,741,363 |
HVCT: Testing: HIV Testing and Counseling | $69,596,329 |
HVSI: Strategic Information | $64,003,201 |
HVOP: Sexual Prevention: Other Sexual Prevention | $59,429,296 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $53,087,840 |
HVTB: Care: TB/HIV | $46,078,732 |
OHSS: Health Systems Strengthening | $37,832,676 |
PDTX: Treatment: Pediatric Treatment | $20,658,988 |
HMBL: Biomedical Prevention: Blood Safety | $20,129,096 |
HMIN: Biomedical Prevention: Injection Safety | $16,832,766 |
PDCS: Care: Pediatric Care and Support | $13,414,780 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $40,000 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
FHI 360:
$233,769,734
Countries/Regions
University of Maryland:
$135,902,858
Countries/Regions
Harvard University:
$124,106,521
Countries/Regions
Not Available:
$121,304,062
Countries/Regions